Adar1 Capital Management, LLC Fulcrum Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $539 Billion
- Q1 2025
A detailed history of Adar1 Capital Management, LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 490,532 shares of FULC stock, worth $3.28 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
490,532
Previous 196,248
149.96%
Holding current value
$3.28 Million
Previous $922 Million
53.16%
% of portfolio
0.26%
Previous 0.18%
Shares
6 transactions
Others Institutions Holding FULC
# of Institutions
120Shares Held
51.6MCall Options Held
48.9KPut Options Held
13.8K-
Ra Capital Management, L.P. Boston, MA10.2MShares$68.3 Million0.61% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$35.1 Million3.64% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.07MShares$33.9 Million0.64% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.82MShares$32.2 Million0.63% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$32.1 Million0.0% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $348M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...